Literature DB >> 22381934

Development and experimental medicine applications of PET in oncology: a historical perspective.

Terry Jones1, Pat Price.   

Abstract

Nearly 90 years of scientific research have led to the use of PET and the ability to forge advances in the field of oncology. In this Historial Review we outline the key developments made with this imaging technique, including the evolution of cyclotrons and scanners, together with the associated advances made in image reconstruction, presentation, analysis of data, and radiochemistry. The applications of PET to experimental medicine are summarised, and we cover how these are related to the use and development of PET, especially in the assessment of tumour biology and pharmacology. The use of PET in clinical oncology and for tissue pharmacokinetic and pharmacodynamic studies as a means of supporting drug development is detailed. The current limitations of the technology are also discussed.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22381934     DOI: 10.1016/S1470-2045(11)70183-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  10 in total

1.  Using Cognitive Neuroscience to Improve Mental Health Treatment: A Comprehensive Review.

Authors:  Jessica A Wojtalik; Shaun M Eack; Matthew J Smith; Matcheri S Keshavan
Journal:  J Soc Social Work Res       Date:  2018-04-27

Review 2.  History and future technical innovation in positron emission tomography.

Authors:  Terry Jones; David Townsend
Journal:  J Med Imaging (Bellingham)       Date:  2017-03-31

3.  PET Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients.

Authors:  Jingjing Zhang; Gang Niu; Xinrong Fan; Lixin Lang; Guozhu Hou; Libo Chen; Huanwen Wu; Zhaohui Zhu; Fang Li; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2017-11-09       Impact factor: 10.057

4.  It's Not What You Take Up, It's What You Keep: How Discoveries from Diverse Disciplines Directed the Development of the FDG PET/CT Scan.

Authors:  Jonathan D Kaunitz; Mark Mandelkern; Joanna S Fowler
Journal:  Dig Dis Sci       Date:  2022-07-30       Impact factor: 3.487

5.  Introduction into PPPM as a new paradigm of public health service: an integrative view.

Authors:  Tatiana A Bodrova; Dmitry S Kostyushev; Elena N Antonova; Shimon Slavin; Dmitry A Gnatenko; Maria O Bocharova; Michael Legg; Paolo Pozzilli; Mikhail A Paltsev; Sergey V Suchkov
Journal:  EPMA J       Date:  2012-11-09       Impact factor: 6.543

6.  Immunohistochemical expression of glucose transporter 1 in keratin-producing odontogenic cysts.

Authors:  Beatriz Vera-Sirera; Leopoldo Forner-Navarro; Francisco Vera-Sempere
Journal:  BMC Oral Health       Date:  2016-03-10       Impact factor: 2.757

7.  Investigation of Association Between Borderline Pancreatic Head Cancer and Glucose Uptake by Using Positron-Emission Tomographic Studies.

Authors:  Ying Zhang; Lei Qin; Changming Zhang
Journal:  Med Sci Monit       Date:  2017-10-16

8.  A Non-invasive Radiomic Method Using 18F-FDG PET Predicts Isocitrate Dehydrogenase Genotype and Prognosis in Patients With Glioma.

Authors:  Longfei Li; Wei Mu; Yaning Wang; Zhenyu Liu; Zehua Liu; Yu Wang; Wenbin Ma; Ziren Kong; Shuo Wang; Xuezhi Zhou; Wei Wei; Xin Cheng; Yusong Lin; Jie Tian
Journal:  Front Oncol       Date:  2019-11-14       Impact factor: 6.244

9.  PET/CT in Oncology: Current Status and Perspectives.

Authors:  Johannes Czernin; Martin Allen-Auerbach; David Nathanson; Ken Herrmann
Journal:  Curr Radiol Rep       Date:  2013-05-03

10.  Development of 1-N-(11)C-Methyl-L- and -D-Tryptophan for pharmacokinetic imaging of the immune checkpoint inhibitor 1-Methyl-Tryptophan.

Authors:  Lin Xie; Jun Maeda; Katsushi Kumata; Joji Yui; Yiding Zhang; Akiko Hatori; Nobuki Nengaki; Hidekatsu Wakizaka; Masayuki Fujinaga; Tomoteru Yamasaki; Yoko Shimoda; Makoto Higuchi; Tetsuya Suhara; Feng Wang; Ming-Rong Zhang
Journal:  Sci Rep       Date:  2015-11-10       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.